Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain assessment, Product use issue, SARS-CoV-2 test
Clinical narrative: Swollen lumps; Left armpit and left breast had engorged lumps; Left armpit and left breast had engorged lumps; Headache; lethargy; shooting pain started deep inside chest - felt like it originated from the heart & radiated outward toward armpit; shooting pain started deep inside chest - felt like it originated from the heart & radiated outward toward armpit; shooting pain started deep inside chest - felt like it originated from the heart & radiated outward toward armpit; Difficult to breathe when shooting pain occurred; bnt162b2 (BNT162B2), administration date 26Nov2021 16:00; influenza vaccine (INFLUENZA), administration date 26Nov2021; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Nov2021 16:00 (Lot number: FD0809) at the age of 56 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (INFLUENZA), administered in arm right, administration date 26Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "known allergis: Yes" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0153, Location of injection: Arm Right, Vaccine Administration Time: 04:00 PM), administration date: 09Apr2021, when the patient was 56 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 18Mar2021, when the patient was 56 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 26Nov2021 16:00, outcome "unknown", described as "Booster"; ANGINA PECTORIS (medically significant), CHEST PAIN (medically significant), AXILLARY PAIN (medically significant) all with onset 27Nov2021, outcome "recovered" and all described as "shooting pain started deep inside chest - felt like it originated from the heart & radiated outward toward armpit"; DYSPNOEA (non-serious) with onset 27Nov2021, outcome "recovered", described as "Difficult to breathe when shooting pain occurred"; AXILLARY MASS (non-serious), BREAST MASS (non-serious) all with onset 27Nov2021 19:00, outcome "recovered" and all described as "Left armpit and left breast had engorged lumps"; NEOPLASM (non-serious), outcome "recovered", described as "Swollen lumps"; HEADACHE (non-serious) with onset 27Nov2021, outcome "recovered" (28Nov2021), described as "Headache"; LETHARGY (non-serious) with onset 27Nov2021, outcome "recovered" (28Nov2021), described as "lethargy"; PRODUCT USE ISSUE (non-serious) with onset 26Nov2021 16:00, outcome "unknown", described as "bnt162b2 (BNT162B2), administration date 26Nov2021 16:00; influenza vaccine (INFLUENZA), administration date 26Nov2021". The patient underwent the following laboratory tests and procedures: pain assessment: (27Nov2021) 7/10, notes: Shooting pain intensity 7/10 (10 being most painful); sars-cov-2 test: (26Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of angina pectoris, chest pain, axillary pain, dyspnoea, axillary mass, breast mass, neoplasm, headache, lethargy. Shooting pain intensity 7/10 (10 being most painful). Shooting pain started Saturday around 8-9 pm. Swollen lumps (lympth nodes) subsided between 01Dec2021 and 02Dec2021. AE treatment includes took 2x 500mg acetaminophen.